Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes - Wikidata - awgldk - TriplyDB

Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes

Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes

http://www.wikidata.org/entity/Q34005217

about

Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective.Immunity to murine chlamydial genital infection.Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins.Chlamydia trachomatis vaccine research through the years.Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms.Contemporary approaches to designing and evaluating vaccines against Chlamydia.Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.ISCOM-based vaccines: the second decade.Delivery of Chlamydia vaccines.Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance.Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis Human antibody responses to a Chlamydia-secreted protease factor Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.Update on Chlamydia trachomatis Vaccinology.Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice.Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae.Structural and Immunological Characterization of Novel Recombinant MOMP-Based Chlamydial Antigens.

P2860

Q34119773-66B14E9D-6710-4162-A662-99D87DE40FCB Q34124225-AC988B44-8C20-4187-9C60-4E658761611E Q34491620-DB3DDAEA-5280-4337-81A0-CDF749193C1F Q35071155-0AEDD140-B8A7-4C01-A9D0-D92D5BB29FB1 Q35113092-149F0F6B-2299-40BD-B73C-293935F9C5A3 Q35193566-CC212840-3887-4370-A730-137D1A326BA9 Q35689196-27E8BAC3-0748-40D3-8276-A9E8D85BEB4A Q36028197-DC4160F5-D5C0-4DC6-8C13-BE99648FE9E6 Q36062124-591ECA94-8EA7-471F-A37C-EBC5BE45BC51 Q36316798-B8CE82FA-D0DA-444A-9F7E-6EB31CC8535F Q36685400-52395C1E-1B6A-4781-B9F9-D24FFE446C49 Q36845154-9C0B3E67-80ED-454B-9109-6C53EEBEDE58 Q36929225-CC7912A8-BDA1-4CB8-A328-113007E0FA7B Q37419766-22D78A26-5154-4296-BC48-F63B5AB16433 Q37623832-95FF7D7E-39F9-4CE2-BFC2-B97C6979DF80 Q37712799-81DCC12A-79E5-4C17-8BD9-F8562952DAE5 Q37834874-79FE3955-E47A-4C62-9087-97C393FF7FD5 Q37845082-7438FFB3-18C0-4C38-B431-CB6B9E0887AC Q37856277-34D3F16E-21DF-4E1F-96EA-A73C02C7900A Q37870760-E0235A6A-C4C5-44C3-BFBD-E02C327DDA2C Q47237292-00638DD6-0C10-42F2-BC7B-25F29F7C0673

P2860

Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes

http://www.wikidata.org/entity/Q34005217

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Induction of protective immuni ...... response-stimulating complexes

@ast

Induction of protective immuni ...... response-stimulating complexes

@en

Induction of protective immuni ...... response-stimulating complexes

@nl

type

label

Induction of protective immuni ...... response-stimulating complexes

@ast

Induction of protective immuni ...... response-stimulating complexes

@en

Induction of protective immuni ...... response-stimulating complexes

@nl

prefLabel

Induction of protective immuni ...... response-stimulating complexes

@ast

Induction of protective immuni ...... response-stimulating complexes

@en

Induction of protective immuni ...... response-stimulating complexes

@nl

P1433

Q34005217-3E9EEB07-B0F1-439B-98A3-820CC17A0B85

P1476

Q34005217-385C35F2-7964-4BFA-BA18-7C6B6ECB01CA

P2093

Q34005217-26A5C80D-BFEA-4F1D-BE11-C0124C1EC575

Q34005217-EB3A4170-CD67-4637-A359-B09CBE56EF86

P2860

Q34005217-003B4C28-B631-4317-873B-DD7891B490F4

Q34005217-08922106-5E40-4DC1-B930-6E4818E1887E

Q34005217-0CC1BC0D-7B06-46FC-8B7F-57889A2BC9F3

Q34005217-11722660-A0C6-4B02-B9F8-DD81C8D551D4

Q34005217-13660426-BB22-4554-9EBA-BFDE71087296

Q34005217-25A267FF-F162-4BE6-A619-387265507B19

Q34005217-26F90580-19FC-495E-94C3-88ABE9A6C663

Q34005217-2B0AC477-D48E-4588-9262-098633F6A46B

Q34005217-2E3961C9-5AE6-4614-812B-03FFA3DF304E

Q34005217-32A39382-50E6-481B-B8BB-71D2FC1B282F

P304

Q34005217-47F1D3A9-35C1-4C8B-A848-3BB2A4A2230A

P31

Q34005217-7E4430AD-EFD1-4EA2-B6A8-338B0B792213

P356

Q34005217-958627BD-AFF3-46DA-BD5B-B46AE02A316C

P407

Q34005217-347B183F-F7D9-4E70-BB56-8AD1406295E1

P433

Q34005217-331CAB42-BE69-433E-BF7B-0DD2CD45CEF2

P478

Q34005217-1CFFDE20-FF3F-482C-8BCB-07EFF511F99B

P577

Q34005217-9D99FA69-841A-4D18-99E5-3469E6620A5E

P5875

Q34005217-9FD70FBF-B4DF-4D1D-B637-F23E60CCB0B9

P698

Q34005217-441F8FDA-D03B-405F-90B2-41AF1AC9F2EA

P921

Q34005217-0C2206D6-7972-4D12-BDFC-058616B9925C

P932

Q34005217-A18C69F9-189B-4C4F-9E52-3BE8634F23D2

P356

IAI.68.12.6798-6806.2000

P1433

Infection and Immunity

P1476

Induction of protective immuni ...... response-stimulating complexes

@en

P2093

A Murdin

http://www.w3.org/2001/XMLSchema#string

J U Igietseme

http://www.w3.org/2001/XMLSchema#string

P2860

Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein

Phylogenetic analysis of the outer-membrane-protein genes of Chlamydiae, and its implication for vaccine development.

The major outer-membrane proteins of Chlamydia trachomatis serovars A and B: intra-serovar amino acid changes do not alter specificities of serovar- and C subspecies-reactive antibody-binding domains.

Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.

A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic.

The potential for vaccine against infection of the genital tract with Chlamydia trachomatis.

Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue

Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.

Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response.

Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses.

P304

6798-6806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.68.12.6798-6806.2000

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12243591

http://www.w3.org/2001/XMLSchema#string

P698

11083798

http://www.w3.org/2001/XMLSchema#string

P921

Chlamydia trachomatis

P932

97783

http://www.w3.org/2001/XMLSchema#string